Press Release Archives - Page 26 of 28 - Simulations Plus

U.S. National Institutes of Health Licenses Simulations Plus’ ClassPharmer™ Software

August 30, 2007
Press Release

U.S. National Institutes of Health Licenses Simulations Plus’ ClassPharmer™ Software

Keywords: chemistry, ClassPharmer, pharmaceutical, U.S. FDA, U.S. National Institutes of Health

Division: PBPK

Another Government Agency Licenses Key Software Product

Read More

U.S. FDA Expands Simulations Plus Software Licenses

August 29, 2007
Press Release

U.S. FDA Expands Simulations Plus Software Licenses

Keywords: computer-based predictive models, in vitro dissolution, in vitro dissolution experiment simulation software, U.S. FDA

Division: PBPK

GastroPlus and DDDPlus Licenses Added

Read More

Simulations Plus Releases Unique Dna Mutation Predictor

July 26, 2007
Press Release

Simulations Plus Releases Unique Dna Mutation Predictor

Keywords: Bioreason, DNA mutations, molecular property prediction program, mutagenicity, salmonella

Software: ADMET Predictor®

Division: PBPK

New Software Screening Tool Helps Pharmaceutical Chemists Predict Drug-Caused DNA Mutations

Read More

Simulations Plus Releases Admet Predictor™ Version 2.3

July 24, 2007
Press Release

Simulations Plus Releases Admet Predictor™ Version 2.3

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, molecular property prediction software, Toxicity

Software: ADMET Predictor®

Division: PBPK

Predictive Accuracy and User Convenience of Best-in-Class Software Now Further Improved

Read More

SImulations Plus to Present at Atlantic City Global Equities Investor Conference July 17

July 13, 2007
Press Release

SImulations Plus to Present at Atlantic City Global Equities Investor Conference July 17

Keywords: investor conference, Summer Global Equities Conference

Division: PBPK

Read More

Simulations Plus Reports Third Quarter FY2007 Financial Results

July 3, 2007
Press Release

Simulations Plus Reports Third Quarter FY2007 Financial Results

Keywords: financial results, gross profit, net income

Division: PBPK

Third Quarter Surpasses Previous Record in Second Quarter

Read More

Simulations Plus Announces Third Quarter Fiscal Year 2007 Earnings Conference Call

June 29, 2007
Press Release

Simulations Plus Announces Third Quarter Fiscal Year 2007 Earnings Conference Call

Keywords: earnings, investor relations

Division: PBPK

Conference Call to be on Thursday, July 5, at 4:15 PM EDT

Read More

Simulations Plus Wins Small Business Innovation Research (SBIR) Grant

June 18, 2007
Press Release

Simulations Plus Wins Small Business Innovation Research (SBIR) Grant

Keywords: ADMET cheminformatics, molecular descriptors, molecular property prediction software, quantum atomic descriptors, Small Business Innovation Research (SBIR)

Division: PBPK

Grant Funds to Speed Commercialization of Improvements to Company's Industry-Leading Molecular Property Prediction Software

Read More

Simulations Plus Set to Join Russell Microcap Index

June 14, 2007
Press Release

Simulations Plus Set to Join Russell Microcap Index

Keywords: investor relations, Russell Microcap Index

Division: PBPK

Read More

Simulations Plus Announces Second Quarter Fiscal Year 2007 Earnings Conference Call

April 23, 2007
Press Release

Simulations Plus Announces Second Quarter Fiscal Year 2007 Earnings Conference Call

Keywords: earnings, investor relations

Division: PBPK

Conference Call to be on Wednesday, April 25, at 4:15 PM EDT

Read More

Simulations Plus Reports Second Quarter FY2007 Financial Results

April 10, 2007
Press Release

Simulations Plus Reports Second Quarter FY2007 Financial Results

Keywords: financial results, investor relations

Division: PBPK

First Six Months' Revenues up 73% and Earnings Jump 1384%

Read More

Simulations Plus Extends Its Software Product Line Into Molecular Drug Design

April 3, 2007
Press Release

Simulations Plus Extends Its Software Product Line Into Molecular Drug Design

Keywords: absorption distribution metabolism and excretion (ADME), ClassPharmer, drug discovery, physicochemical properties, Toxicity

Division: PBPK

Unique Computer Aided Drug Design Capability Added To Company's ClassPharmer™ Software

Read More

Updated Guidance Provided for Fiscal Year 2007 Revenues

February 26, 2007
Press Release

Updated Guidance Provided for Fiscal Year 2007 Revenues

Keywords: investor relations

Division: PBPK

Simulations Plus Reports Results Of Annual Meeting

Read More

Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus

February 12, 2007
Press Release

Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus

Keywords: five-year extension, oral absorption, pharmaceutical, pharmacokinetics

Division: PBPK

Contract Signals Long-Term Demand for Simulations Plus' Software and Consulting Services

Read More

ANTI-HIV Predictive Models Released by Simulations Plus

January 31, 2007
Press Release

ANTI-HIV Predictive Models Released by Simulations Plus

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, AIDS, anti-HIV agents, Toxicity

Division: PBPK

Extensions to ADMET Predictor(™) Software Enhance Anti-HIV Activity Discovery Capabilities

Read More

Simulations Plus to Present at RedChip Investor Conference February 12 in Tempe, Arizona

January 25, 2007
Press Release

Simulations Plus to Present at RedChip Investor Conference February 12 in Tempe, Arizona

Keywords: investor conference

Division: PBPK

Read More

Simulations Plus Reports First Quarter FY2007 Financial Results

January 16, 2007
Press Release

Simulations Plus Reports First Quarter FY2007 Financial Results

Keywords: financial results, investor relations, net income

Division: PBPK

Record First Quarter Sees Pharmaceutical Revenues Jump 314%

Read More

Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call

January 10, 2007
Press Release

Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call

Keywords: earnings, investor relations

Division: PBPK

Conference Call to be on Tuesday, January 16, at 4:15 PM EST

Read More

Simulations Plus Flagship Software To Aid Government Research Projects

January 9, 2007
Press Release

Simulations Plus Flagship Software To Aid Government Research Projects

Keywords: in vitro dissolution experiment simulation software, PBPK modeling program, The U.S. Food and Drug Administration

Division: PBPK

U.S. FDA Licenses GastroPlus(™)

Read More

Simulations Plus Receives Another Large Pharmaceutical Software License Renewal

December 21, 2006
Press Release

Simulations Plus Receives Another Large Pharmaceutical Software License Renewal

Keywords: investor relations

Division: PBPK

Large Pharmaceutical Company Renews Global Software Licenses

Read More

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Advertisement

Others